2,028 results on '"Reardon, Michael J."'
Search Results
2. Cardiac Neoplasms
3. Transcatheter or Surgical Aortic Valve Replacement in Women With Small Annuli at Low or Intermediate Surgical Risk
4. Predictors and Trends of New Permanent Pacemaker Implantation: A Subanalysis of the International Navitor IDE Study
5. Long-Term Outcomes of Transcatheter vs Surgical Aortic Valve Replacement: Meta-analysis of Randomized Trials
6. Improved Hemodynamics With Self-Expanding Compared to Balloon-Expandable Transcatheter Aortic Valve Implantation in Small Annulus Patients: A Propensity-Matched Analysis
7. Current definitions of hemodynamic structural valve deterioration after bioprosthetic aortic valve replacement lack consistency
8. Reinterventions After CoreValve/Evolut Transcatheter or Surgical Aortic Valve Replacement for Treatment of Severe Aortic Stenosis
9. Five-Year Follow-Up from the CoreValve Expanded Use Transcatheter Aortic Valve-in-Surgical Aortic Valve Study
10. Do postoperative hemodynamic parameters add prognostic value for mortality after surgical aortic valve replacement?
11. Decreasing pacemaker implantation rates with Evolut supra-annular transcatheter aortic valves in a large real-world registry
12. Bicuspid Aortic Valve Disease: Classifications, Treatments, and Emerging Transcatheter Paradigms
13. Transcatheter aortic valve implantation in patients with bicuspid valve morphology: a roadmap towards standardization
14. The robustness of the flow-gradient classification of severe aortic stenosis
15. Aortic valve versus root surgery after failed transcatheter aortic valve replacement
16. Outcomes Based on Angiographic vs Functional Significance of Complex 3-Vessel Coronary Disease: FAME 3 Trial
17. Primary cardiac sarcomas: Treatment strategies
18. Predicting 5-Year Clinical Outcomes After Transcatheter or Surgical Aortic Valve Replacement (a Risk Score from the SURTAVI Trial)
19. Feasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study
20. First-in-Human Multicenter Experience of the Newest Generation Supra-Annular Self-Expanding Evolut FX TAVR System
21. An Updated Meta-Analysis on Cerebral Embolic Protection in Patients Undergoing Transcatheter Aortic Valve Intervention Stratified by Baseline Surgical Risk and Device Type
22. Surgical risks
23. Contributors
24. Impact of Mitral Regurgitation Etiology on Mitral Surgery After Transcatheter Edge-to-Edge Repair: From the CUTTING-EDGE Registry
25. Explant vs Redo-TAVR After Transcatheter Valve Failure: Mid-Term Outcomes From the EXPLANTORREDO-TAVR International Registry
26. TAVR in 2023: Who Should Not Get It?
27. Lower Blood Pressure After Transcatheter or Surgical Aortic Valve Replacement is Associated with Increased Mortality
28. 30-Day Clinical Outcomes of a Self-Expanding Transcatheter Aortic Valve: The International PORTICO NG Study
29. Outcomes of Full and Partial Cardiac Autotransplantation for Complex Left-Sided Heart Tumors
30. Early and late effects of aortic root enlargement: Results from the Pericardial Surgical Aortic Valve Replacement Pivotal Trial: A multicenter, prospective clinical trial
31. Surgical Explantation of Failed Transcatheter Aortic Valve Replacement
32. Surgical Management of Primary Pulmonary Artery Sarcoma
33. Propensity-Matched Outcomes Comparing TAVR in Bicuspid vs Surgery in Tricuspid Aortic Valve Stenosis
34. Impact of Left Atrial Pressure on Outcomes After Mitral Transcatheter Edge-to-Edge Repair
35. Myocardial Blood Flow Reserve, Microvascular Coronary Health, and Myocardial Remodeling in Patients With Aortic Stenosis
36. Examining the typical hemodynamic performance of nearly 3000 modern surgical aortic bioprostheses
37. What did the transcatheter aortic valve replacement-surgical aortic valve replacement (TAVR-SAVR) trials tell us?
38. Prognostic Value of Right Ventricular Afterload in Patients Undergoing Mitral Transcatheter Edge‐to‐Edge Repair
39. Imaging, Treatment Options, Patient Selection, and Outcome Considerations for Patients With Bicuspid Aortic Valve Disease
40. Why the categorization of indexed effective orifice area is not justified for the classification of prosthesis–patient mismatch
41. Primary cardiac lymphoma
42. Management of primary cardiac paraganglioma
43. Transcatheter Mitral Valve Replacement Versus Medical Therapy for Secondary Mitral Regurgitation: A Propensity Score–Matched Comparison
44. Differential proteome profile, biological pathways, and network relationships of osteogenic proteins in calcified human aortic valves
45. 2-Year Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients
46. Primary Pericardial Mesothelioma: A Population-Based Propensity Score-Matched Analysis
47. Surgical Techniques for Removal and Replacement of Chronically Implanted TAVR Prosthesis: Step by Step
48. 3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study.
49. Transcatheter Aortic Valve Replacement in Large Annuli Valves With the Supra-Annular, Self-Expandable Evolut Platform in a Real-World Registry
50. Echocardiographic Profiling Predicts Clinical Outcomes After Mitral Transcatheter Edge‐to‐Edge Repair
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.